Towards quantitative and multiplexed in vivo functional cancer genomics

Reviews

Towards quantitative and multiplexed in vivo functional cancer genomics

Towards quantitative and multiplexed in vivo functional cancer genomics, Published online: 28 September 2018; doi:10.1038/s41576-018-0053-7

CRISPR–Cas genome editing and next-generation sequencing are driving advances in cancer modelling and functional cancer genomics. Their application to autochthonous mouse models of human cancer to generate and analyse multiplexed and/or combinatorial alterations in vivo is reviewed here.

Articles You May Like

<i>N</i>6-mA marks the spot
When Hospitals Merge to Save Money, Patients Often Pay More
1CellBio and the Open Medicine Institute to Demonstrate Power of Single-Cell RNA Sequencing in Precision Medicine Applications
Towards a molecular basis of ubiquitin signaling: A dual-scale simulation study of ubiquitin dimers
UK Data Watchdog Monitors Google’s Absorption Of DeepMind App Used By NHS

Leave a Reply

Your email address will not be published. Required fields are marked *